Details

Autor(en) / Beteiligte

• Giersing, Birgitte K
• Modjarrad, Kayvon
• Kaslow, David C
• Moorthy, Vasee S

Titel

Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015

Ist Teil von

• Vaccine, 2016-06, Vol.34 (26), p.2865-2869

Ort / Verlag

Netherlands: Elsevier Ltd

Erscheinungsjahr

2016

Quelle

Access via ScienceDirect (Elsevier)

Beschreibungen/Notizen

• Highlights • The RTS,S Plasmodium falciparum malaria vaccine has received a positive regulatory assessment by EMA. • The CYD-TDV dengue vaccine has been licensed in some middle-income countries. • A Phase 3 HIV vaccine trial is due to be initiated in South Africa during 2016–2017. • The RSV vaccine pipeline is in Phase III clinical development and may reach the licensure submission stage within 4 years. • Group B streptococcal vaccine development is advancing, as is the maternal immunisation agenda. • Within the novel enteric vaccines area, Norovirus, ETEC and Shigella pipelines are all advancing.